Tufts Center for the Study of Drug Development
192 South Street, Suite 550
7 articles about Tufts Center for the Study of Drug Development
Industry executives often lament the fact that clinical trials take a long time to complete and often fail. BioSpace spoke with Tufts' Ken Getz about possible reasons and solutions.
Tufts CSDD Demonstrates Multi-Million-Dollar Benefits of Translational Pharmaceutics®
The Tufts CSDD study assessed development cycle times and their financial benefits by using data compiled on completed Translational Pharmaceutics projects to benchmark against industry drug development durations.
New Oversight Scorecard Dovetails With Benchmark Research On CRO Outsourcing Practices.
Comprehend reveals new solution at DIA 2019, designed for clinical trial process improvement and greater ICH E6(R2) compliance.
Rising Protocol Complexity Is Hindering Performance while Driving Up Cost of Clinical Trials, According to the Tufts Center for the Study of Drug Development
Rising protocol complexity is hindering clinical trial performance and efficiency, and helping to drive up the cost of developing new drugs, according to a recently completed analysis by the Tufts Center for the Study of Drug Development.
MSF Scorns Tufts Center (An Affiliate of Tufts University) Study On Cost To Develop Drugs
Tufts Health Plan Named To Top 10 National Health Plans By The National Committee For Quality Assurance
Tufts Health Plan Introduces Health Savings Accounts For Small Business Owners